Glaucoma and obstructive sleep apnoea syndrome

Clinical and Experimental Ophthalmology

Volumn 40, Issue 4, 2012, Pages 408-419

  Faridi, Omar ^a   Park, Sung Chul ^a,b   Liebmann, Jeffrey M ^a,c   Ritch, Robert ^a,b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CPAP; Glaucoma; Normal tension glaucoma; Sleep apnoea

Indexed keywords

AUTONOMIC DYSFUNCTION; CARDIOVASCULAR SYSTEM; DISEASE ASSOCIATION; GLAUCOMA; HUMAN; HYPERCAPNIA; INFLAMMATION; INTRAOCULAR PRESSURE; ISCHEMIA; MITOCHONDRION; OPTIC NERVE; OXIDATIVE STRESS; REVIEW; SLEEP APNEA SYNDROME;

GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; SLEEP APNEA, OBSTRUCTIVE;

EID: 84862542346     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2012.02768.x     Document Type: Review

References (105)

1. Strollo PJ Jr, Rogers R. Current concepts: obstructive sleep apnea. N Engl J Med 1996; 334: 99-104.
2. Waller EW, Bendel RE, Kaplan J. Sleep disorders and the eye. Mayo Clin Proc 2008; 83: 1251-61.
3. Ghergel D, Hosking SL, Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 2004; 49: 491-508.
4. Caprioli J, Coleman AL. Perspective: blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol 2010; 149: 704-12.
5. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993; 328: 303-7.
6. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002; 165: 1217-39.
7. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
8. Wang H, Parker JD, Newton GE etal. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007; 17: 1625-31.
9. Chobanian AV, Bakris GL, Black HR etal. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
10. Lattimore JD, Celermajer DS, Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol 2003; 41: 1429-37.
11. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2000; 342: 1378-84.
12. Ip MS, Tse HF, Lam B, Tsang KW, Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169: 348-53.
13. Olson LJ, Olson EJ, Somers VK. Obstructive sleep apnea and platelet activation: another potential link between sleep-disordered breathing and cardiovascular disease. Chest 2004; 126: 339-41.
14. Fletcher EC. Sympathetic overactivity in the etiology of hypertension of obstructive sleep apnea. Sleep 2003; 26: 15-19.
15. Kato M, Thomson PR, Phillips BG etal. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-10.
16. Jelic S, Padeletti M, Kawut SM etal. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 2008; 117: 2270-8.
17. McNab AA. Floppy eyelid syndrome and obstructive sleep apnea. Ophthal Plast Reconstr Surg 1997; 13: 98-114.
18. McNab AA. The eye and sleep. Clin Experiment Ophthalmol 2005; 33: 117-25.
19. Mojon DS, Goldblum D, Fleischhauer J etal. Eyelid, conjunctival, and corneal findings in sleep apnea syndrome. Ophthalmology 1999; 106: 1182-5.
20. Netland PA, Sugrue SP, Albert DM, Shore JW. Histopathologic features of the floppy eyelid syndrome: involvement of tarsal elastin. Ophthalmology 1994; 101: 174-81.
21. Schlötzer-Schrehardt U, Stojkovic M, Hofmann-Rummelt C, Cursiefen C, Kruse FE, Holbach LM. The pathogenesis of floppy eyelid syndrome: involvement of matrix metalloproteinases in elastic fiber degradation. Ophthalmology 2005; 112: 694-704.
22. Lindsey M, Wedin K, Brown MD etal. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 2001; 103: 2181-7.
23. Mojon DS, Hedges TR III, Ehrenberg B etal. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 2002; 120: 601-5.
24. Palombi K, Renard E, Levy P etal. Non-arteritic anterior ischemic optic neuropathy is nearly systematically associated with obstructive sleep apnea. Br J Ophthalmol 2006; 90: 879-82.
25. Mojon DS, Mathis J, Zulauf M, Koerner F, Hess CW. Optic neuropathy associated with sleep apnea syndrome. Ophthalmology 1998; 105: 874-7.
26. Bucci FA, Krohel GB. Optic nerve swelling secondary to the obstructive sleep apnea syndrome. Am J Ophthalmol 1986; 105: 428-30.
27. Lee AG, Golnik K, Kardon R, Wall M, Eggenberger E, Yedavally S. Sleep apnea and intracranial hypertension in men. Ophthalmology 2002; 109: 482-5.
28. Sugita Y, Iijima S, Teshima Y etal. Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome. Electroencephalogr Clin Neurophysiol 1985; 60: 214-19.
29. Gordon MO, Beiser JA, Brandt JD etal. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 714-20.
30. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z. Predictors of long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology 2007; 114: 1965-72.
31. Miglior S, Torri V, Zeyen T, Pfeiffer N, Vaz JC, Adamsons I. European Glaucoma Prevention Study (EGPS) Group. Intercurrent factors associated with the development of open-angle glaucoma in the European Glaucoma Prevention Study. Am J Ophthalmol 2007; 144: 266-75.
32. Leske MC, Wu SY, Hennis A, Honkanen RA, Nemesure B. BESs Study Group. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology 2008; 115: 85-93.
33. Nakagami T, Yamazaki Y, Hayamizu F. Prognostic factors for progression of visual field damage in patients with normal-tension glaucoma. Jpn J Ophthalmol 2006; 50: 38-43.
34. De Moraes CGV, Prata TS, Liebmann CA, Tello C, Ritch R, Liebmann JM. Spatially-consistent, localized visual field loss precedes and follows disc hemorrhage in glaucomatous eyes. Invest Ophthalmol Vis Sci 2009; 50: 4727-33.
35. Walsh JT, Montplaisir J. Familial glaucoma with sleep apnoea: a new syndrome? Thorax 1982; 37: 845-9.
36. Robert PY, Adenis JP, Tapie P, Melloni B. Eyelid hyperlaxity and obstructive sleep apnea (O.S.A.) syndrome. Eur J Ophthalmol 1997; 7: 211-15.
37. Mojon DS, Hess CW, Goldblum D etal. High prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology 1999; 106: 1009-12.
38. Sergi M, Salerno DE, Rizzi M etal. Prevalence of normal tension glaucoma in obstructive sleep apnea syndrome patients. J Glaucoma 2007; 16: 42-6.
39. Lin PW, Friedman MW, Lin HC, Chang HW, Wilson M, Lin MC. Normal tension glaucoma in patients with obstructive sleep apnea/hypopnea syndrome. J Glaucoma 2011; 20: 553-8.
40. Bendel RE, Kaplan J, Heckman M, Fredrickson PA, Lin SC. Prevalence of glaucoma in patients with obstructive sleep apnoea - a cross-sectional case-series. Eye 2008; 22: 1105-9.
41. Karakucuk S, Goktas S, Aksu M etal. Ocular blood flow in patients with obstructive sleep apnea syndrome (OSAS). Graefes Arch Clin Exp Ophthalmol 2008; 246: 129-34.
42. Geyer O, Cohen N, Segev E etal. The prevalence of glaucoma in patients with sleep apnea syndrome: same as in the general population. Am J Ophthalmol 2003; 136: 1093-6.
43. Mojon DS, Hess CW, Goldblum D, Böhnke M, Körner F, Mathis J. Primary open-angle glaucoma is associated with sleep apnea syndrome. Ophthalmologica 2000; 214: 115-18.
44. Mojon DS, Hess CW, Goldblum D etal. Normal-tension glaucoma is associated with sleep apnea syndrome. Ophthalmologica 2002; 216: 180-4.
45. Marcus DM, Costarides AP, Gokhale P etal. Sleep disorders: a risk factor for normal-tension glaucoma? J Glaucoma 2001; 10: 177-83.
46. Blumen Ohana E, Blumen MB, Bluwol E, Derri M, Chabolle F, Nordmann JP. Primary open angle glaucoma and snoring: prevalence of OSAS. Eur Ann Otorhinolaryngol Head Neck Dis 2010; 127: 159-64.
47. Girkin CA, McGwin G Jr, McNeal SF, Owsley C. Is there an association between pre-existing sleep apnoea and the development of glaucoma? Br J Ophthalmol 2006; 90: 679-81.
48. Klein BEK, Klein R, Sponsel WE etal. Prevalence of Glaucoma: the beaver dam eye study. Ophthalmology 1992; 99: 1499-504.
49. Tsang CSL, Chong SL, Ho CK, Li MF. Moderate to severe obstructive sleep apnoea patients is associated with a higher incidence of visual field defects. Eye 2006; 20: 38-42.
50. Kargi SH, Altin R, Koksal M etal. Retinal nerve fibre layer measurements are reduced in patients with obstructive sleep apnea syndrome. Eye 2005; 19: 575-9.
51. Lin PW, Friedman M, Lin HC, Chang HW, Pulver TM, Chin CH. Decreased retinal nerve fiber layer thickness in patients with obstructive sleep apnea/hypopnea syndrome. Graefes Arch Clin Exp Ophthalmol 2011; 249: 585-93.
52. Onen SH, Mouriaux F, Berramdane L, Dascotte JC, Kulik JF, Rouland JF. High prevalence of sleep-disordered breathing in patients with primary open-angle glaucoma. Acta Ophthalmol Scand 2000; 78: 638-41.
53. Kremmer S, Niederdräing N, Ayertey HD, Steuhl KP, Selbach JM. Obstructive sleep apnea syndrome, normal tension glaucoma, and nCPAP therapy - a short note. Sleep 2003; 26: 161-2.
54. Sebastian RT, Johns S, Gibson RA. Treating obstructive sleep apnoea syndrome: does it improve visual field changes? Eye 2006; 20: 118-20.
55. Roberts TV, Hodge C, Graham SL, Burlutsky G, Mitchell P. Prevalence of nocturnal oxygen desaturation and self-reported sleep-disordered breathing in glaucoma. J Glaucoma 2009; 18: 114-18.
56. Boonyaleephan S, Neruntarat C. The association of primary open-angle glaucoma / normal tension glaucoma and obstructive sleep apnea in Thai patients. J Med Health Sci 2008; 15: 86-93.
57. Stein JD, Kim DS, Mundy KM etal. The association between glaucomatous and other causes of optic neuropathy and sleep apnea. Am J Ophthalmol 2011; 152: 989-98.
58. Barkana Y, Anis S, Liebmann JM, Tello C, Ritch R. Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol 2006; 124: 793-7.
59. Liu JH, Zhang X, Kripke DF, Weinreb RN. Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci 2003; 44: 1586-90.
60. Mosaed S, Liu JH, Weinreb RN. Correlation between office and peak nocturnal intraocular pressures in healthy subjects and glaucoma patients. Am J Ophthalmol 2005; 139: 320-4.
61. Brubaker RF. Flow of aqueous humor in humans [The Friedenwald Lecture]. Invest Ophthalmol Vis Sci 1991; 32: 3145-66.
62. Prata TS, de Moraes CG, Kanadani FN, Ritch R, Paranhos A Jr. Posture-induced intraocular pressure changes: considerations regarding body position in glaucoma patients. Surv Ophthalmol 2010; 55: 445-53.
63. Pepin JL, Chiquet C, Tamisier R, Levy P, Almanjoumi A, Romanet JP. Frequent loss of nyctohemeral rhythm of intraocular pressure restored by nCPAP treatment in patients with severe apnea. Arch Ophthalmol 2010; 128: 1257-63.
64. Deokule S, Weinreb RN. Relationships among systemic blood pressure, intraocular pressure, and open-angle glaucoma. Can J Ophthalmol 2008; 43: 302-7.
65. Lundmark PO, Trope GE, Flanagan JG. The effect of simulated obstructive apnea on IOP and pulsatile ocular blood flow in healthy young adults. Br J Ophthalmol 2003; 87: 1363-9.
66. Goldblum D, Mathis J, Bohnke M etal. [Nocturnal measurements of intraocular pressure in patients with normal-tension glaucoma and sleep apnea syndrome]. Klin Monatsbl Augenheilkd 2000; 216: 246-9.
67. Drance SM. Some factors in the production of low-tension glaucoma. Br J Ophthalmol 1972; 56: 229-42.
68. Leske MC. Ocular perfusion pressure and glaucoma: clinical trial and epidemiologic findings. Curr Opin Ophthalmol 2009; 20: 73-8.
69. Graham SL, Drance SM. Nocturnal hypotension: role in glaucoma progression. Surv Ophthalmol 1999; 43 (Suppl. 1): S10-6.
70. Plange N, Kaup M, Daneljan L, Predel HG, Remky A, Arend O. 24-h blood pressure monitoring in normal tension glaucoma: night-time blood pressure variability. J Hum Hypertens 2006; 20: 137-42.
71. Collignon N, Dewe W, Guillaume S, Collignon-Brach J. Ambulatory blood pressure monitoring in glaucoma patients. The nocturnal systolic dip and its relationship with disease progression. Int Ophthalmol 1998; 22: 19-25.
72. Tokunaga T, Kashiwagi K, Tsumura T, Taguchi K, Tsukahara S. Association between nocturnal blood pressure reduction and progression of visual field defect in patients with primary open-angle glaucoma or normal-tension glaucoma. Jpn J Ophthalmol 2004; 48: 380-5.
73. Detry M, Boschi A, Ellinghais G, De Plaen JF. Simultaneous 24-h monitoring of intraocular pressure and arterial blood pressure in patients with progressive and non-progressive primary open-angle glaucoma. Eur J Ophthalmol 1996; 6: 273-8.
74. Kashiwagi K, Hosaka O, Kashiwagi F etal. Systemic circulatory parameters. comparison between patients with normal tension glaucoma and normal subjects using ambulatory monitoring. Jpn J Ophthalmol 2001; 45: 388-96.
75. Liu M, Takahashi H, Morita Y etal. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 563-9.
76. Higashi Y, Nakagawa K, Kimura M etal. Circadian variation of blood pressure and endothelial function in patients with essential hypertension: a comparison of dippers and non-dippers. J Am Coll Cardiol 2002; 40: 2039-43.
77. Stradling JR, Pepperell JCT, Davies RJO. Sleep apnoea and hypertension: proof at last? Thorax 2001; 56: 45-9.
78. Arabi Y, Morgan BJ, Goodman B, Puleo DS, Xie A, Skatrud JB. Daytime blood pressure elevation after nocturnal hypoxia. J Appl Physiol 1999; 87: 689-98.
79. Ramar K, Caples S. Vascular changes, cardiovascular disease and obstructive sleep apnea. Future Cardiol 2011; 7: 241-9.
80. Moller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-h blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16: 274-80.
81. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987; 10: 35-44.
82. Priou P, Gagnadoux F, Tesse A etal. Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea. Am J Pathol 2010; 177: 974-83.
83. Cross MD, Mills NL, Al-Abri M etal. Continuous positive airway pressure improves vascular function in obstructive sleep apnea/hypopnea syndrome: a randomized controlled trial. Thorax 2008; 63: 578-83.
84. Noda A, Nakata S, Koike Y etal. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res 2007; 30: 669-76.
85. Sugiyama T, Moriya S, Oku H, Azuma I. Association of endothelin-1 with normal-tension glaucoma: clinical and fundamental studies. Surv Ophthalmol 1995; 39 (Suppl.): 49-56.
86. Baguet JP, Hammer L, Levy P etal. Night-time and diastolic dysfunction hypertension are common and underestimated conditions in newly diagnosed apneic patients. J Hypertens 2005; 23: 512-17.
87. Leung DYL, Tham CCY, Li FCH, Kwong YY, Chi SC, Lam DS. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma. Ophthalmology 2009; 116: 1250-6.
88. Stroman GA, Stewart WC, Golnik KC, Cure JK, Olinger RE. Magnetic resonance imaging in patients with low-tension glaucoma. Arch Ophthalmol 1995; 113: 168-72.
89. Suzuki J, Tomidokoro A, Araie M etal. Visual field damage in normal-tension glaucoma patients with or without ischemic changes in cerebral magnetic resonance imaging. Jpn J Ophthalmol 2004; 48: 340-4.
90. Kaiser HJ, Flammer J, Burckhardt D. Silent myocardial ischemia in glaucoma patients. Ophthalmologica 1993; 207: 6-7.
91. Eguchi K, Kario K, Hoshide S, Ishikawa J, Morinari M, Shimada K. Nocturnal hypoxia is associated with silent cerebrovascular disease in high-risk Japanese community-dwelling population. Am J Hypertens 2005; 18: 1489-95.
92. Drance S, Anderson D, Schulzer M; Collaborative Normal-Tension Glaucoma Study Group. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol 2001; 131: 699-708.
93. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest 1995; 108: 625-30.
94. Wedzicha JA, Syndercombe-Court D, Tan KC. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxemia. Thorax 1991; 46: 504-7.
95. Hui DS, Ko FW, Fok JP etal. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 2004; 125: 1768-175.
96. O'Brien C, Butt Z, Ludlam C, Detkova P. Activation of the coagulation cascade in untreated primary open-angle glaucoma. Ophthalmology 1997; 104: 725-30.
97. Trope GE, Salinas RG, Glynn M. Blood viscosity in primary open-angle glaucoma. Can J Ophthalmol 1987; 22: 202-4.
98. Lavie L. Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis 2009; 51: 303-12.
99. Christou K, Markoulis N, Moulas AN, Pastaka C, Gourgoulianis KI. Reactive oxygen metabolites as an index of oxidative stress in obstructive sleep apnea patients. Sleep Breath 2003; 7: 105-10.
100. Christou K, Kostikas K, Pastaka C, Tanou K, Antoniadou I, Gourgoulianis KI. Nasal continuous positive airway pressure treatment reduces oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med 2009; 10: 87-94.
101. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnoea syndrome. Circulation 2005; 112: 2660-7.
102. Liu Q, Ju WK, Crowston JG etal. Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Invest Ophthalmol Vis Sci 2007; 48: 4580-9.
103. Hosking SL, Evans DW, Embleton SJ, Houde B, Amos JF, Bartlett JD. Hypercapnia invokes an acute loss of contrast sensitivity in untreated glaucoma patients. Br J Ophthalmol 2001; 85: 1352-6.
104. Hosking SL, Harris A, Chung HS etal. Ocular haemodynamic responses to induced hypercapnia and hyperoxia in glaucoma. Br J Ophthalmol 2004; 88: 406-11.
105. Evans DW, Harris A, Garrett M, Chung HS, Kagemann L. Glaucoma patients demonstrate faulty autoregulation of ocular blood flow during posture change. Br J Ophthalmol 1999; 83: 809-13.